Skip to main content
. 2001 Jul 23;2001(3):CD001360. doi: 10.1002/14651858.CD001360

Summary of findings for the main comparison. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION for schizophrenia and severe mental illness.

INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION for schizophrenia and severe mental illness
Patient or population: patients with schizophrenia and severe mental illness 
 Settings: in hospital 
 Intervention: INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION
Outcomes Illustrative comparative risks* (95% CI) Relative effect 
 (95% CI) No of Participants 
 (studies) Quality of the evidence 
 (GRADE) Comments
Assumed risk Corresponding risk
Control INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION
Committed suicide by three years 42 per 1000 22 per 1000 
 (2 to 234) RR 0.52 
 (0.05 to 5.56) 94 
 (1 study) ⊕⊕⊝⊝ 
 low1,2  
Global impression: 1. Not able to be discharged (long term) 42 per 1000 351 per 1000 
 (85 to 1000) RR 8.35 
 (2.03 to 34.3) 94 
 (1 study) ⊕⊕⊝⊝ 
 low1,2  
Global impression: 2. Given medication during 12 months to three years follow up ‐ by 12 months 958 per 1000 613 per 1000 
 (479 to 776) RR 0.64 
 (0.5 to 0.81) 94 
 (1 study) ⊕⊕⊝⊝ 
 low1,2  
Global impression: 2. Given medication during 12 months to three years follow up ‐ by three years 1000 per 1000 850 per 1000 
 (750 to 960) RR 0.85 
 (0.75 to 0.96) 94 
 (1 study) ⊕⊕⊝⊝ 
 low1,2  
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). 
 CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence 
 High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. 
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. 
 Very low quality: We are very uncertain about the estimate.

1 Randomisation undertaken but not clearly described. 
 2 One small single study.